BioVie Inc. (BIVI) Securities Class Action: The litigation focuses on the propriety of BioVie’s disclosures concerning its adherence to Good Clinical Practice (“GCP”) and protocols related to its ...
This week, markets across the board have remained relatively calm, with price action reflecting a clear consolidation phase. The Nasdaq, for instance, has formed an inside bar on the weekly chart, ...
The SEC’s temporary de minimis thresholds for security-based swap dealing activity ($8 billion for credit default swaps and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback